OPTIMIS
Timeline
19 events since 2008Capital
Filings
Financial
2008201020122014201620182020202220242026
2019
Annual accounts 2018 filed PDFfull format · 6 days before the deadline
Merger: absorbed by NEWPHARMA GROUPCancellation of 186 shares · NEWPHARMA GROUP holds all the shares · General meeting of 28-05-20194 points ▸
- General meeting, 28-05-2019
- Accounting effect, 01-01-2019
- NEWPHARMA GROUP holds all the shares
- Net-asset statement, 31-12-2018
- The deed holds 15 more points.
Merger proposal: to be absorbed by NEWPHARMA GROUPPermanent representatives: Dieter Struye, Jérôme Gobbesso, Dries Colpaert, Olivier Witmeur and Thomas De Kempeneer · NEWPHARMA GROUP holds all the shares · Board meeting of 02-04-201916 points ▸
- Board meeting, 02-04-2019
- Board composition, ETABLISSEMENTEN FRANZ COLRUYT (director)
- Board composition, JGO (director)
- Board composition, KORYS BUSINESS SERVICES I NV (director)
- Board composition, ORGANISATION-MANAGEMENT-CONSULTANCY and RELATIONS (director)
- Board composition, KORYS MANAGEMENT (director)
- Permanent representative, Dieter Struye
- Permanent representative, Jérôme Gobbesso, mentioned 3 times in the deed
- Permanent representative, Dries Colpaert
- Permanent representative, Olivier Witmeur
- Permanent representative, Thomas De Kempeneer
- Capital, €67,500,000, 67,500 shares
- Capital, €18,600, 186 shares, mentioned twice in the deed
- Board composition, JGO (sole manager), mentioned twice in the deed
- Accounting effect, 01-01-2019
- NEWPHARMA GROUP holds all the shares
- The deed holds 9 more points.
2018
Liquidity more than doubled current ratio 2.38 The current ratio rises from 1.06 to 2.38. Short-term debt falls from €91,776 to €992.
Annual accounts 2017 filed PDFfull format · on the deadline day
2017
Annual accounts 2016 filed PDFmicro format · 18 days before the deadline
2016
Annual accounts 2015 filed PDFabbreviated format · 9 days late
2015
Annual accounts 2014 filed PDFabbreviated format · 54 days late
2014
Highest result from 2008 to 2018 net €467,922 ▲777% The operating result of €72,154 and the net result of €467,922 are both a record.
Equity above €500,000 equity €506,622 ▲1,209% After 2 profitable years in a row, equity reaches €506,622.
Annual accounts 2013 filed PDFabbreviated format · 29 days late
2013
Back to profit net €53,336 The net result is €53,336, after one loss-making year.
Annual accounts 2012 filed PDFabbreviated format · 26 days before the deadline
2012
Annual accounts 2011 filed PDFabbreviated format · 26 days before the deadline
2011
Annual accounts 2010 filed PDFabbreviated format · 44 days before the deadline
2010
Annual accounts 2009 filed PDFabbreviated format · 53 days before the deadline
2009
Back to profit net €343 The net result is €343, after one loss-making year.
Annual accounts 2008 filed PDFabbreviated format · 1 day before the deadline
2008
Incorporation PDF7 publications in the Belgian Official Gazette, the last on 27-06-2019
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank